| Applications: |
Immunodepletion/Immunocompetition |
| Reactivity: |
Human |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
C1ORF115 Blocking Peptide for STJ506176 is synthetically produced from the 75-125 sequence and is suitable for use in western blot applications. |
| Formulation: |
Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Storage Instruction: |
Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
| Gene Symbol: |
C1orf115 |
| Gene ID: |
79762 |
| Uniprot ID: |
RDD1_HUMAN |
| Immunogen Region: |
75-125 |
| Specificity: |
This blocking peptide is recommended for use in combination with C1ORF115 antibody, STJ506176 |
| Immunogen: |
Synthetic peptide taken within amino aid region 75-125 on human Chromosome 1 Open Reading Frame 115. |
| Peptide Name | Required For Drug-Induced Death Protein 1 |
| Cellular Localisation | MembraneSingle-Pass Membrane Protein |
| Alternative Peptide Names | Required For Drug-Induced Death Protein 1 proteinC1orf115 proteinRDD1 protein |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
